| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 42,890 | 42,530 | 43,003 | 47,325 | | Cost of Revenue | 5,531 | 5,874 | 6,892 | 8,863 | | | Gross Profit |
-
| 36,656 | 36,111 | 38,462 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 20,367 | 25,314 | 23,181 | 21,843 | | Non Recurring | 2,779 |
-
|
-
| 19,511 | | Others | 16,500 | 21,000 | 11,000 | (5,267) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (9,658) | 1,930 | 2,375 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (2,287) | (9,658) | 1,930 | 2,375 | | Interest Expense | 1,051 | 1,125 | 1,234 | 1,785 | | Income Before Tax | (3,338) | (10,783) | 696 | 590 | | Income Tax Expense | (1,836) | (5,253) | (816) | (1,224) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,502) | (5,530) | 1,512 | 1,814 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,502) | (5,530) | 1,512 | 1,814 | | Preferred Stock And Other Adjustments |
-
| (1,111) | (1,093) |
-
| | | Net Income Applicable To Common Shares | ($2,596) | ($6,641) | $419 | $1,814 |
|
0.03% Nasdaq 
0.28 (1.73%) 
Income Statement
